Keyword: Boehringer Ingelheim
News
21.01.2015
- CPhI Worldwide has announced the launch of a new advisory board, consisting of the following industry experts who provide a wide expertise portfolio: Alan Sheppard, Principal...
News
16.01.2015
- Under a deal just signed, German drugmaker Boehringer Ingelheim will offer its production capabilities for monoclonal antibodies to French pharmaceutical producer Sanofi to support...
News
24.10.2014
- Boehringer Ingelheim is not bidding for Belgian over-the-counter drugmaker Omega Pharma, a company spokesperson has confirmed. News agencies reported earlier this week that the...
News
16.10.2014
- Bayer soon may find itself regretting its decision to sell its plastics business and become a pure life science player. According to international press reports, the German group's...
News
10.07.2014
- Centroflora CMS (C2 Pharma), a specialist in active pharmaceutical ingredients (APIs), has acquired manufacturing assets for a group of phytochemical APIs from German drugmaker...
News
30.06.2014
- The European Medicine Agency (EMA) has recommended approval of Abasria, Eli Lilly's biosimilar version of Sanofi's insulin glargine sold as Lantus. This means that the French...
News
02.06.2014
- Danish drugmaker Novo Nordisk, the world's biggest insulin producer, has decided to launch its diabetes drug Tresiba in Germany after seeing signs of a more favorable pricing...
News
02.06.2014
- German drugmaker Boehringer Ingelheim has said it will pay about $650 million to settle US lawsuits that claimed the company's blockbuster blood thinner, Pradaxa (dabigatran)...
